Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to Novel Psilocybin and Derivates Program from Arbormentis LLC
News
Ride Health and the American Heart Association Partner to Improve Health Equity for Patients Facing Transportation Barriers
American Heart Association’s Social Impact Fund and Bernard J. Tyson Impact Fund invest $500,000 to support comprehensive patient transportation programs at renowned hospitals
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing
– IMM-BCP-01 already shown to neutralize all other CDC variants of concern in pre-clinical testing
– IND submission planned for this quarter
CrossBridge Health acquires Geisinger-developed PACER software
CrossBridge to integrate PACER intelligence to improve outcomes for patients with chronic inflammatory diseases
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy
Envara Health Named Winner of 2021 PACT Enterprise Awards
Nutrition Company Redefining ‘Food as Medicine’ Recognized for Commitment to Science-Backed Technology in the Life Sciences Industry
Renovacor Announces the Appointments of Joan Lau, Ph.D., and Gregory F. Covino to its Board of Directors
Appointments to be effective upon closing of the previously announced merger between Renovacor and Chardan Healthcare Acquisition 2 Corp.
Venatorx Pharmaceuticals Announces First Patient Dosed in Phase 1 Study of VNRX-9945 for the Treatment of Chronic Hepatitis B Virus Infection